February 11, 2019 9:35 am
Published by jonas
Redwood Pharma will be attending BIO-Europe 2019 in Vienna, Mar. 25 – 27 to meet and continue discussions with potential... View Article
February 4, 2019 8:00 am
Published by jonas
in Redwood Pharma Phase II study
February 4, 2019 8:00 am
Published by jonas
Redwood Pharma AB (publ) today announces that the first patient has begun testing ofRP101 in a Phase II clinical trial.... View Article
February 4, 2019 8:00 am
Published by jonas
Redwood Pharma AB (publ) meddelar idag att första patienten har börjat behandlas i företagets Fas-II prövning. RP101 är en innovativ... View Article
January 9, 2019 2:31 pm
Published by jonas
Pressmeddelande 2019-01-09 Den 8 oktober 2018 beslutade Redwood Pharma AB (”Redwood”) om en till den danska fonden Formue Nord Markedsneutral... View Article
January 7, 2019 9:12 pm
Published by jonas
Redwood Pharma receives its third and last national approval
January 7, 2019 9:07 pm
Published by jonas
Redwood Pharma has now also received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate... View Article
January 7, 2019 9:07 pm
Published by jonas
Redwood Pharma har erhållit godkännande från det tyska läkemedelsverket (BfArM) att inleda den kliniska prövningen av RP101, bolagets nya läkemedelskandidat... View Article
December 14, 2018 8:00 am
Published by jonas
Redwood Pharma has now also received approval from the Austrian Federal Office for Safety in Health Care (BASG / AGES)... View Article
December 14, 2018 8:00 am
Published by jonas
Redwood Pharma har nu även erhållit godkännande från det österrikiska läkemedelsverket (BASG/AGES) att inleda den kliniska prövningen av RP101, bolagets... View Article